Synthesis 2017; 49(07): 1531-1537
DOI: 10.1055/s-0036-1588105
paper
© Georg Thieme Verlag Stuttgart · New York

Total Syntheses of Urgineanins A, B, D, and Their Analogues

Dileep Kumar Singh
College of Pharmacy and Yonsei Institute of Pharmaceutical Sciences, Yonsei University, 85 Songdogwahak-ro, Yeonsu-gu, Incheon 21983, Republic of Korea   Email: ikyonkim@yonsei.ac.kr
,
Youngeun Jung
College of Pharmacy and Yonsei Institute of Pharmaceutical Sciences, Yonsei University, 85 Songdogwahak-ro, Yeonsu-gu, Incheon 21983, Republic of Korea   Email: ikyonkim@yonsei.ac.kr
,
Ikyon Kim*
College of Pharmacy and Yonsei Institute of Pharmaceutical Sciences, Yonsei University, 85 Songdogwahak-ro, Yeonsu-gu, Incheon 21983, Republic of Korea   Email: ikyonkim@yonsei.ac.kr
› Author Affiliations
Further Information

Publication History

Received: 10 September 2016

Accepted after revision: 01 November 2016

Publication Date:
28 November 2016 (online)


Abstract

The first asymmetric total syntheses of urgineanins A, B, and D – potent antiproliferative homoisoflavonoids – were achieved by utilizing Pd-catalyzed allylic substitution of the allylic acetate with arylboronic acids for introduction of the C rings of homoisoflavonoid skeleton. Several unnatural urgineanin analogues were also prepared in this manner.

Supporting Information

 
  • References


    • For reviews, see:
    • 1a Abegaz BM, Mutanyatta-Comar J, Nindi M. Nat. Prod. Commun. 2007; 2: 475
    • 1b Lin L.-G, Liu Q.-Y, Ye Y. Planta Med. 2014; 80: 1053
    • 2a Juranek I, Suchy V, Stara D, Masterova I, Grancaiova Z. Pharmazie 1993; 48: 310
    • 2b Shim JS, Kim JH, Lee J, Kim SN, Kwon HJ. Planta Med. 2004; 70: 171
    • 2c Siddaiah V, Rao CV, Venkateswarlu S, Krishnaraju AV, Subbaraju GV. Bioorg. Med. Chem. 2006; 14: 2545
    • 2d Jeong HJ, Kim YM, Kim JH, Kim JY, Park J.-Y, Park S.-J, Ryu YB, Lee WS. Biol. Pharm. Bull. 2012; 35: 786
    • 2e Namdar R, Makouie N, Nafisi S. J. Photochem. Photobiol., B 2013; 128: 100
    • 2f Basavarajappa HD, Lee B, Lee H, Sulaiman RS, An H, Magana C, Shadmand M, Vayl A, Rajashekhar G, Kim E.-Y, Suh Y.-G, Lee K, Seo S.-Y, Corson TW. J. Med. Chem. 2015; 58: 5015
    • 3a Siddaiah V, Rao CV, Venkateswarlu S, Subbaraju GV. Tetrahedron 2006; 62: 841
    • 3b Gan C, Zhao Z, Nan D.-D, Yin B, Hu J. Eur. J. Med. Chem. 2014; 76: 125
    • 3c Javed U, Karim M, Jahng KC, Park J.-G, Jahng Y. Tetrahedron: Asymmetry 2014; 25: 1270
    • 3d Das U, Lorand T, Dimmock SG, Perjesi P, Dimmock JR. J. Enzyme Inhib. Med. Chem. 2015; 30: 259
    • 3e Hou C, Chen H, Xu X, Zhu F, Guo L, Jiang M, Yang C, Deng L. Eur. J. Org. Chem. 2015; 3040
  • 4 Dai Y, Harinantenaina L, Brodie PJ, Goetz M, Shen Y, TenDyke K, Kingston DG. I. J. Nat. Prod. 2013; 76: 865
  • 5 Jung Y, Kim I. Org. Biomol. Chem. 2015; 13: 4331
    • 6a Venugopalan B, Balasubramanian KK. Heterocycles 1985; 23: 81
    • 6b Kenny RS, Mashelkar UC, Rane DM, Bezawada DK. Tetrahedron 2006; 62: 9280
  • 7 Synthesis of 6 was initially attempted by using the similar procedures as those reported in ref. 5. But the yield was low.
    • 8a Pd-catalyzed allylic substitution of allylic alcohol was also conducted under base-free conditions but resulted in very low yield of 3a.
    • 8b See: Tsukamoto H, Sato M, Kondo Y. Chem. Commun. 2004; 1200
    • 8c See also: Tsukamoto H, Uchiyama T, Suzuki T, Kondo Y. Org. Biomol. Chem. 2008; 6: 3005

      For reviews on IBX, see:
    • 9a Tohma H, Kita Y. Adv. Synth. Catal. 2004; 346: 111
    • 9b Duschek A, Kirsch SF. Angew. Chem. Int. Ed. 2011; 50: 1524

    • For the oxidation of alcohols with IBX in EtOAc, see:
    • 9c More JD, Finney NS. Org. Lett. 2002; 4: 3001
    • 9d Bartlett SL, Beaudry CM. J. Org. Chem. 2011; 76: 9852
  • 10 Kolb HC, Van Nieuwenhze MS, Sharpless KB. Chem. Rev. 1994; 94: 2483
  • 11 The ers of 8a and 8b were determined by chiral HPLC analysis (CHIRALPAK IA column; flow, 0.5 mL min–1; H2O–MeCN = 50:50; λ = 254 nm). See Supporting Infromation for details.
  • 12 The er of 8e was determined by chiral HPLC analysis (CHIRALPAK IA column; flow, 0.5 mL min–1; H2O–MeCN = 50:50; λ = 254 nm). The ers of 8c and 8d were determined by chiral HPLC analysis (CHIRALPAK IC column; flow, 1 mL min–1; hexane–EtOH = 80:20; λ = 210 nm). The er of 8f was determined by chiral HPLC analysis (CHIRALPAK IA column; flow, 0.5 mL min–1; H2O–MeCN = 60:40; λ = 254 nm). See Supporting Information for details.